Cell Source, Inc.

OTC:CLCS

0.5 (USD) • At close November 27, 2023
Bedrijfsnaam Cell Source, Inc.
Symbool CLCS
Munteenheid USD
Prijs 0.498
Beurswaarde 19,002,311
Dividendpercentage 0%
52-weken bereik 0 - 1.5
Industrie Biotechnology
Sector Healthcare
CEO Mr. Itamar Shimrat
Website https://www.cell-source.com

An error occurred while fetching data.

Over Cell Source, Inc.

Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in

Vergelijkbare Aandelen

Vext Science, Inc. logo

Vext Science, Inc.

VEXTF

0.215 USD

Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc.

PVCT

0.149 USD

Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc.

PBSV

0.98 USD

HealthLynked Corp. logo

HealthLynked Corp.

HLYK

0.038 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)